| Literature DB >> 8750758 |
J M Johnston1, P Grondziowski, R M Windisch, R A Eder, L Lytle.
Abstract
A feasibility study was undertaken to evaluate laboratory phlebotomists performing bedside glucose monitoring (BGM) over a 3-month period on a medical and surgical floor. Specific questions included: feasibility of providing testing on a 24-h basis, accuracy, appropriate utilization, effect on patient care, and an analysis of cost. In all, 1975 tests were performed on 114 patients. BGM results were within 15% of the laboratory's result 97% of the time. Patient and physician satisfaction was high. Although the cost of BGM is slightly higher than a laboratory glucose test, its use appeared to reduce the length of hospital stay by 0.47 days. Practical information on initiating a highly successful BGM program is provided.Entities:
Mesh:
Substances:
Year: 1995 PMID: 8750758 DOI: 10.1007/bf00576252
Source DB: PubMed Journal: Acta Diabetol ISSN: 0940-5429 Impact factor: 4.280